Form 4: Roivant Sciences CFO Disposes Shares for Tax Obligations Following RSU Vesting

Roivant Sciences Ltd.'s CFO, Richard Pulik, disposed of 1,653 common shares at $10.62 each to cover tax withholding obligations related to RSU vesting.

Summary

• Richard Pulik, the Chief Financial Officer (CFO) of Roivant Sciences Ltd. (ROIV), reported a transaction on May 28, 2025.
• The transaction involved the disposition of 1,653 common shares.
• The shares were disposed of at a price of $10.62 per share.
• This disposition was a "net settlement" by the Issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of previously granted Restricted Stock Units (RSUs).
• Following this transaction, Richard Pulik beneficially owns 400,559 common shares directly.

Sentiment

Score: 5

Explanation: The transaction is a routine disposition of shares for tax withholding purposes upon RSU vesting, which is a neutral event and does not indicate a change in management's sentiment or company performance.

Positives

• The vesting of Restricted Stock Units (RSUs) indicates the fulfillment of certain performance or tenure conditions by the CFO, reflecting a standard compensation event.

Negatives

• The disposition of shares, while for tax purposes, results in a minor reduction of the CFO's direct shareholding by 1,653 shares.

Future Outlook

NA

Management Comments

• The transaction represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation and tax obligations, which does not directly reflect broader industry trends or competitive dynamics.

Related Party Transactions

• The disposition of shares is a "net settlement" of previously granted Restricted Stock Units (RSUs) to satisfy tax withholding obligations, which is a standard compensation-related transaction between the company and its CFO.

Stakeholder Impact

• Shareholders: The transaction is a routine tax-related disposition and does not indicate a change in the CFO's long-term commitment or a significant impact on the company's financial health. The CFO retains substantial beneficial ownership.
• Employees: No direct impact on general employees.

Key Dates

Recommendation

Keywords

Roivant Sciences, ROIV, Form 4, Insider Transaction, CFO, Share Disposition, RSU, Tax Withholding, Beneficial Ownership